• Please log in or register to access this feature.

Letter to the Editor

SURROGATE, FRIEND OR FOE? THE NEED FOR CASE STUDIES OF THE USE OF SURROGATE OUTCOMES IN COST-EFFECTIVENESS ANALYSES

  1. O. Ciani*,
  2. R. S. Taylor

Article first published online: 24 MAY 2012

DOI: 10.1002/hec.2826

Issue

Health Economics

Health Economics

Volume 22, Issue 2, pages 251–252, February 2013

Additional Information

How to Cite

Ciani, O. and Taylor, R. S. (2013), SURROGATE, FRIEND OR FOE? THE NEED FOR CASE STUDIES OF THE USE OF SURROGATE OUTCOMES IN COST-EFFECTIVENESS ANALYSES. Health Econ., 22: 251–252. doi: 10.1002/hec.2826

Author Information

  1. Peninsula Technology Assessment Group, Peninsula Medical School, University of Exeter, Exeter, EX2 4SG, UK

*Peninsula Technology Assessment Group, Peninsula Medical School, University of Exeter, Salmon Pool Lane, Exeter EX2 4SG, UK. E-mail: oriana.ciani@pcmd.ac.uk

Publication History

  1. Issue published online: 9 JAN 2013
  2. Article first published online: 24 MAY 2012
  3. Manuscript Accepted: 2 APR 2012
  4. Manuscript Revised: 21 FEB 2012
  5. Manuscript Received: 8 SEP 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (44K)

Keywords:

  • surrogate outcomes;
  • health technology assessment

SUMMARY

We comment on a recent article by Hawkins et al. presenting different analytic approaches for the inclusion of surrogate and final outcomes in cost-effectiveness analyses. This methodological case study provides a timely and valuable contribution to build on the debate about the use of evidence based on surrogate outcomes in health technology assessment. Copyright © 2012 John Wiley & Sons, Ltd.

View Full Article (HTML) Get PDF (44K)